Damora Therapeutics, Inc. ($DMRA)
Filing Information
| Accession Number | 0001193125-26-297818 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,605
Total Value
$7,345.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Jul 3, 2026 | Exercise/Conversion | 680 | โ | โ | 2,534 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Jul 6, 2026 | Sale | 245 | $29.98 | $7,345.10 | 2,289 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Jul 3, 2026 | Exercise/Conversion | 680 | $0.00 | $0.00 | 640 | Direct | โ | View Details |